Oncofertility Research Pitfall? Recall Bias in Young Adult Cancer Survivors
Overview
Affiliations
Objective: To assess recall bias by evaluating how well female cancer survivors remember details regarding their cancer diagnosis, treatment, and fertility preservation (FP) counseling.Oncofertility literature cites recall bias as a pitfall of retrospective surveys, but limited data exist to quantify this bias.
Design: Retrospective secondary analysis of cross-sectional survey data.
Setting: Single academic medical center.
Patients: Female oncology patients of reproductive age, 18-44 years old, at least 6 months past their last chemotherapy treatment.
Interventions: Not applicable.
Main Outcome Measures: Recall of details surrounding cancer diagnosis and chemotherapy regimens, recall of FP counseling and ovarian reserve testing, and rates of chart-documented FP counseling.
Results: In total, 117 patients completed the survey, with 112 verified via chart review. When asked to report the chemotherapy regimen, 57% (64 of the 112) marked "I don't know/prefer not to say." Regarding FP, 80% (90 of the 112) denied being offered counseling. Of the 37 (33%) who had documented FP conversations, 13 (35%) did not recall mention of fertility. Only 2 of 8 patients with ovarian reserve testing recalled this being performed at their initial visit. Multivariable logistic regression revealed older age was significantly associated with not being offered FP (odds ratio [OR] 0.87).
Conclusions: Our results confirm that the accuracy of oncology patients' reporting is limited by a poor recall, particularly regarding their specific chemotherapy regimen. More than 1 in 3 patients documented to have been offered FP counseling do not recall this discussion. Importantly, only one-third of cancer survivors had chart-documented FP counseling. Increased efforts are needed to ensure adequate follow-up beyond the initial visit.
Pecoriello J, Quinn G, Hade E, Reinecke J J Assist Reprod Genet. 2024; 41(10):2807-2812.
PMID: 39083108 PMC: 11535109. DOI: 10.1007/s10815-024-03217-3.
George S, Veludhandi A, Xiang Y, Liu K, Stenger E, Arnold S Transplant Cell Ther. 2024; 30(9):912.e1-912.e13.
PMID: 38972510 PMC: 11344653. DOI: 10.1016/j.jtct.2024.06.029.